Celebrating 30 years of helping you give wisely
America's most independent,
assertive charity watchdog
Top Rated

National Kidney Foundation

CharityWatch report issued
October 2022

Top-Rated Charity
CharityWatch Grade
Our independent grade based
on a number of factors.
Program Percentage
Amount spent on programs
relative to overhead.
Cost to Raise $100
Amount spent to raise
$100 of contributions.

Contact Information

National Kidney Foundation
30 East 33rd St.
New York, NY 10016

Other Names


Tax Status




Stated Mission

To prevent kidney diseases, improve the health & well-being of individuals & families affected by these diseases, and increase the availability of all organs for transplantation.

View similar charities
Against Malaria Foundation  
ALS Association (National Office)  
American Brain Tumor Association  
American Diabetes Association  
American Heart Association  
American Kidney Fund  
American Leprosy Missions  
American Liver Foundation  
American Lung Association  
American Parkinson Disease Association  
American Sexual Health Association  
Arthritis Foundation  
Bone Health and Osteoporosis Foundation  
BrightFocus Foundation  
CDC Foundation  
Christopher & Dana Reeve Foundation  
City of Hope & Affiliates  
Crohn's & Colitis Foundation  
Cystic Fibrosis Foundation  
Defeat Diabetes Foundation  
Diabetes Action Research and Education Foundation  
Diabetes Research & Wellness Foundation  
Diabetes Research Institute Foundation  
Easterseals (National Office)  
Elizabeth Glaser Pediatric AIDS Foundation  
Epilepsy Foundation  
Foundation for AIDS Research (amfAR)  
Hearing Health Foundation  
Heart Center of America (DISSOLVED)  
Huntington's Disease Society of America  
JDRF International  
Lupus Foundation of America (National Office)  
Lupus Research Alliance  
March of Dimes  
MedicAlert Foundation United States  
Mercy Ships & Affiliates  
Michael J. Fox Foundation for Parkinson's Research  
Miracle Flights  
Multiple Sclerosis Association of America  
Multiple Sclerosis Foundation  
Muscular Dystrophy Association  
National Caregiving Foundation  
National Emergency Medicine Association (DISSOLVED)  
National Hemophilia Foundation (National Office)  
National Jewish Health  
National Multiple Sclerosis Society  
National Psoriasis Foundation  
Operation Smile  
Parkinson Research Foundation  
Parkinson's Foundation  
Partnership for a Healthier America  
PKD Foundation  
Project Cure  
Salk Institute for Biological Studies  
San Francisco AIDS Foundation  
Shriners Hospitals for Children  
Smile Train  
United Cerebral Palsy (National Office)  
Will Rogers Motion Picture Pioneers Foundation  
WonderWork (DISSOLVED)  
Data based on Fiscal Year Ended 03/31/2021

Program Percentage: 84%

The percentage of National Kidney Foundation's cash budget it spends on programs relative to overhead (fundraising, management, and general expenses).


Calculated Total Expenses



Cost to Raise $100: $12

How many dollars National Kidney Foundation spends on fundraising to raise each $100 of contributions.


Calculated Total Contributions


Government Funding

0% to 24%

Percentage of cash revenue
coming from government sources


Financial Documents

Entity Document Type Tax ID
National Kidney Foundation IRS Form 990 13-1673104
National Kidney Foundation Audited Financial Statements 13-1673104
Entity: National Kidney Foundation
Document Type: IRS Form 990
Tax ID: 13-1673104
Entity: National Kidney Foundation
Document Type: Audited Financial Statements
Tax ID: 13-1673104

Governance & Transparency

CharityWatch evaluates certain criteria related to a charity's Governance and Transparency. Donors may want to consider a charity's willingness to be open and transparent with CharityWatch to be a good litmus test for determining its commitment to public accountability.
This charity is Top-Rated
What does it mean to be Top-Rated?
National Kidney Foundation
meets governance benchmarks.
National Kidney Foundation
meets transparency benchmarks.
Provides Financial Information
Audit Accessibility
Governance: Policies
Reports regularly & consistently monitoring & enforcing compliance with a written Conflict of Interest Policy
Reports required, annual disclosure by officers, directors, and key staff of interests that could give rise to conflicts
Reports having a written Whistleblower Policy
Reports having a written Document Retention and Destruction Policy
Governance: Financials
Reports providing copy of tax form to all board members prior to filing it with IRS
Reports that financial statements were audited by an independent accountant
Governance: Board of Directors
Reports at least 5 voting board members
51% or more of voting board members reported as independent
Reports documenting minutes of board and board committee meetings
Privacy Policy
Privacy Policy Opt-In Policy  

  Name Title Compensation
1 Kevin Longino CEO $445,163
2 Kerry K. Willis Chief Scientific Officer $349,362
3 Petros A. Gregoriou CFO $309,945
Name: Kevin Longino
Title: CEO
Compensation: $445,163
Name: Kerry K. Willis
Title: Chief Scientific Officer
Compensation: $349,362
Name: Petros A. Gregoriou
Title: CFO
Compensation: $309,945

CharityWatch Analysts perform an in-depth analysis of charities' audited financial statements and IRS tax filings, and often review other documents such as state filings, annual reports, and fundraising contracts during their evaluations. Below are select notes that CharityWatch believes may be of interest to donors.

According to the National Kidney Foundation audit of March 31, 2021 (Note 1, Nature of Organization):

"...The Foundation has a chartered network of nine affiliated organizations (Affiliates) and 29 regional offices as of March 31, 2021 across the country to implement its mission... Under the provisions of a charter with the Foundation, each Affiliate must meet certain requirements regarding organizational structure, program services, and fundraising."

CharityWatch's rating of the National Kidney Foundation does not include the financial activities of its nine Affiliates.

As described in the National Kidney Foundation (NKF) fiscal 2021 tax filing: "...The Affiliates are separate legal entities (not controlled by NKF) which in tandem with the Foundation help implement its mission... NKF and its Affiliates have agreements under which a portion of contributions received by Affiliates is shared with NKF for the express purpose of fulfilling its mission" (IRS Form 990, Schedule O re: Form 990, Part III, line 4b).

According to the National Kidney Foundation audit of March 31, 2021 (Note 10, Loan Payable – Paycheck Protection Program):

"The Coronavirus Aid, Relief, and Economic Security Act (the CARES Act) appropriated funds for the Small Business Administration (SBA) Paycheck Protection Program (PPP) loans that are forgivable in certain situations to promote continued employment... In April 2020, the Foundation applied for and secured a PPP loan of approximately $3.6 million. The Foundation has reported the PPP Loan as a liability on its balance sheet as of March 31, 2021. Management has assessed and concluded that the funds were used in accordance with the SBA stipulations and are eligible for receiving full forgiveness from the SBA (see Note 18 [cited below] for related subsequent event updated disclosures)."

According to the National Kidney Foundation audit of March 31, 2021 (Note 18, Subsequent Events):

"In April 2021, the Foundation has applied for full forgiveness on the SBA PPP loan. On June 22, 2021, the Foundation received notice from its banker that the SBA has authorized the full forgiveness of the loan. As such, the bank will apply the forgiveness to the Foundation's loan account and offset all interest accrued. The forgiveness amount will be reported in the Foundation's results for fiscal year 2022."

According to the National Kidney Foundation audit of March 31, 2021 (Note 16, Related-Party Transactions):

"During the years ended March 31, 2021 and 2020, the Foundation had an arm's length transaction with a board member. The board member is a president of a marketing agency that has been engaged to work on the Foundation's Kidney Risk Campaign, known as the 'Are you the 33%' awareness campaign (Campaign). The marketing agency assisted the Foundation with the creative aspects of the Campaign, as well as the engagement and distribution channels for the Campaign.

"During the years ended March 31, 2021 and 2020, the amounts paid to the marketing agency for the various deliverables of the Campaign approximated $386,025 and $685,000, respectively. This amount includes both compensation for the marketing agency, as well as passthrough costs for the engagement and distribution aspects of the Campaign..."

According to the National Kidney Foundation audit of March 31, 2021 (Note 17, Risks and Uncertainties, Investments Risk):

"In the normal course of business, the Foundation enters into transactions in various financial instruments with off-balance sheet risk. Market risk represents the potential loss that can be caused by a change in the fair value of the financial instrument. Liquidity risk represents the possibility that the Foundation may not be able to rapidly adjust the size of its positions in times of high volatility and financial stress at a reasonable price. The Foundation is subject to credit risk if the investment managers are unable to repay balances due or deliver securities in their custody. Due to the level of risk associated with certain investments and the level of uncertainty related to the changes in fair value of these investments, it is at least reasonably possible that changes in market conditions in the near term could materially affect the value of investments reported in the [audited] financial statements."

According to the National Kidney Foundation audit of March 31, 2021 (Note 17, Risks and Uncertainties, COVID-19 Outbreak):

"On January 30, 2020, the World Health Organization (WHO) announced a global health emergency because of a new strain of coronavirus... In March 2020, the WHO classified the COVID-19 outbreak as a pandemic...

"Although the Centers for Disease Control (CDC) and most states have lifted most of the restrictions put in place to contain COVID-19 as of the report date [August 6, 2021], the full impact of the COVID-19 outbreak continues to evolve as of the date of this report. As such, it is uncertain as to the full magnitude of the impact that the pandemic will have on the Foundation's future financial condition, liquidity, and results of operations. Management is actively monitoring the impact of the situation on its financial condition, liquidity, operations, suppliers, industry, and workforce. Given the evolution of new variants with the COVID-19 outbreak and the global responses to curb its spread, the Foundation is not able to accurately estimate the effects of the COVID-19 outbreak on its results of operations, financial condition, or liquidity for fiscal year 2022. The Foundation's operations are heavily dependent on private and public donations from individuals, foundations, and corporations for all its events around the United States. Apart from the Golf program and some of its other special events and programs that already began in-person activities, the Foundation is projecting that in-person Walks can safely resume in January 2022.

"On March 27, 2020, the CARES Act was signed into law. ... As detailed in Note 10 [cited separately, above], the Foundation obtained a PPP loan from the appropriations of the CARES Act, no other forms of assistance were utilized as of March 31, 2021."

According to the National Kidney Foundation (NKF) tax filing for the fiscal year ended March 31, 2021, NKF reports re: Compensation, Supplemental Information (IRS Form 990, Schedule J, Part III):

Regarding nonfixed payments to officers, directors, trustees, key employees and highest compensated employees (Schedule J, Part I, Line 7):

"Schedule J, Part II, Column (B)(ii) ['Bonus & incentive compensation'] reports discretionary incentive amounts that were approved by the compensation committee based upon individual and organizational performance."

NKF reports "Bonus & incentive compensation" payments to 11 individuals in calendar year 2020, including $76,000 paid to Kevin Longino, Chief Executive Officer, whose reported total compensation in 2020 is $445,163. The reported "Bonus & incentive compensation" amounts for the other 10 individuals range between $19,594 and $3,800, with associated reported total compensation ranging from $349,362 to $198,473 (IRS Form 990, Schedule J, Part II).

Related Articles

No related articles found